Pa. maker of placenta-derived tissue graft obtains $2.23M

02/12/2013 | MedCityNews.com

AFcell Medical has obtained $2.23 million of a targeted $10 million round, which it will use for its sales and marketing team. The Pennsylvania-based startup is the maker of AmnioClear, a tissue graft derived from the placenta of living human donors that could speed recovery for tendon surgery or wound repair patients.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ